Skip to content
President Biden’s executive order announced March 18 calls for coordinated federal action and an investment of $200 million to promote research into women’s health, […]
Biden’s executive order on women’s health research includes $200M for NIH Read More »
X-Therma, a member of the Biotechnology Innovation Organization (BIO), recently announced significant strides towards changing the future of organ preservation and transportation. On March
X-Therma hints at what’s next: a revolution in organ transplantation and preservation Read More »
Antimicrobial resistance (AMR) is a health concern with growing global significance. AMR, which is developed resistance to antimicrobial treatments in bacteria, fungi, parasites, and
BIO Ventures for Global Health combats AMR through R&D in Africa Read More »
The human microbiome is a frontier charged with the potential to revolutionize health and medicine. The latest episode of the I am BIO Podcast,
I am BIO Podcast explores the potential of the human microbiome Read More »
During the State of the Union address on March 7, President Biden said, “Women are more than half of our population, but research on
BIO’s Women’s Health Task Force fosters greater innovation in women’s health Read More »
President Biden delivered his third State of the Union address last night, March 7. Health care was a prominent theme throughout the night, which
Key takeaways from the State of the Union address Read More »
The Biotechnology Innovation Organization (BIO) 2024 CEO and Investor Conference (a.k.a. #BIOCEO24) took place February 26-27 in New York. The annual event brought together
A few more things from #BIOCEO24… Read More »
Biotech CEOs weathering a lean investment market got some good news from a panel of experts on Feb. 27. Following a couple of painfully
The biotech IPO outlook is strong, say experts Read More »
The World Trade Organization (WTO) 13th Ministerial concluded on Friday, March 1, without an agreement to expand the COVID-19 intellectual property waiver to therapeutics
WTO Ministerial ends, no expansion of COVID IP waiver Read More »
Sickle cell disease (SCD) patients were given new hope in late 2023 when the Food and Drug Administration (FDA) approved two novel treatments. One
Could CRISPR be the answer to sickle cell disease? Read More »
